Biotech company Novavax said today that its COVID-19 vaccine has been shown to be 90.4% safe and effective overall in phase 3 clinical trials for nearly 30,000 participants across the United States and Mexico. Also, it was found that the two-dose vaccine is 100% effective in preventing moderate and severe …
Read More »